Mark H. Ravich - Jun 17, 2021 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Role
Director
Signature
/s/ Michael G. Costello, Attorney-in-Fact for Mark H. Ravich
Stock symbol
RMTI
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 05:27 PM
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Award $0 +50K +24.56% $0.00 254K Jun 17, 2021 Direct F1
holding RMTI Common Stock 16K Jun 17, 2021 By: Alyssa Danielle Ravich 1991 Irrevocable Trust F2
holding RMTI Common Stock 9K Jun 17, 2021 By: Alexander Coleman Ravich 1991 Irrevocable Trust F3
holding RMTI Common Stock 220K Jun 17, 2021 BY: Revocable Trust of Mark H Ravich F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMTI Stock Option (Right to Buy) Award $0 +72.9K $0.00 72.9K Jun 17, 2021 Common Stock 72.9K $0.90 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer.
F2 Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust.
F3 Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust.
F4 Represents securities owned directly by Revocable Trust of Mark H Ravich ("MHR Trust"). Mr. Ravich, as the trustee of MHR Trust, may be deemed to beneficially own the securities owned directly by MHR Trust.
F5 Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer.